aTyr Pharma | LIFE - Selling And Administration Expenses


aTyr Pharma reported $700.63K in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Alterity Therapeutics Limited AUD 1.45M 703.96K Dec/2025
Ardelyx USD 102.27M 26.35M Mar/2026
aTyr Pharma USD 700.63K 81.56M Mar/2026
Biogen USD 709.7M 155.4M Jun/2026
Bristol-Myers Squibb USD 1.83B 209M Jun/2026
Cipla INR 13.25B 101.8M Dec/2025
Clal Biotechnology ILS 3.31M 513K Dec/2022
Compugen USD 2.43M 222K Mar/2026
CSL USD 1.23B 498M Dec/2025
Curis USD 2.96M 1.62M Mar/2026
GlaxoSmithKline GBP 2.19B 75M Jun/2026
Grifols EUR 320.45M 12.65M Dec/2025
Lakefront Biotherapeutics EUR 35.5M 8.91M Mar/2026
Novartis USD 3.24B 101M Jun/2026
Roche Holding CHF 6.37B 908M Jun/2026
United Therapeutics USD 156.6M 34M Mar/2026